These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-Km in a transfused man with McLeod syndrome. White W; Washington ED; Sabo BH; Stroup M; McCreary J; Oyen R; Marsh WL Rev Fr Transfus Immunohematol; 1980; 23(3):305-17. PubMed ID: 7406997 [TBL] [Abstract][Full Text] [Related]
4. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km. Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163 [TBL] [Abstract][Full Text] [Related]
5. Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen. Redman CM; Marsh WL; Scarborough A; Johnson CL; Rabin BI; Overbeeke M Br J Haematol; 1988 Jan; 68(1):131-6. PubMed ID: 3345289 [TBL] [Abstract][Full Text] [Related]
6. Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells. Branch DR; Sy Siok Hian AL; Petz LD Br J Haematol; 1985 Mar; 59(3):505-12. PubMed ID: 2578808 [TBL] [Abstract][Full Text] [Related]
7. Autoanti-K5(Ku) in a patient with lymphoma. Krikler SH; Turner-Lienaux K; Godin T; Miller W Vox Sang; 1987; 52(1-2):157. PubMed ID: 3604162 [No Abstract] [Full Text] [Related]
8. A murine monoclonal antibody against Kx protein which reacts also with beta-spectrin. Carbonnet F; Blanchard D; Hattab C; Cochet S; Petit-Leroux Y; Loirat MJ; Cartron JP; Bertrand O Transfus Med; 2000 Jun; 10(2):145-54. PubMed ID: 10849386 [TBL] [Abstract][Full Text] [Related]
9. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease. Russo DC; Oyen R; Powell VI; Perry S; Hitchcock J; Redman CM; Reid ME Transfusion; 2000 Nov; 40(11):1371-5. PubMed ID: 11099667 [TBL] [Abstract][Full Text] [Related]
10. Another example of mimicking anti-Kpb in a Kp(a+b-) patient. Puig N; Carbonell F; Marty ML Vox Sang; 1986; 51(1):57-9. PubMed ID: 3739324 [TBL] [Abstract][Full Text] [Related]
11. Acquired loss of red cell Kell antigens. Vengelen-Tyler V; Gonzalez B; Garratty G; Kruppe C; Johnson CL; Mueller KA; Marsh WL Br J Haematol; 1987 Feb; 65(2):231-4. PubMed ID: 3828231 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune hemolytic anemia and the Kell blood groups. Marsh WL; Oyen R; Alicea E; Linter M; Horton S Am J Hematol; 1979; 7(2):155-62. PubMed ID: 539592 [TBL] [Abstract][Full Text] [Related]
13. Autoimmunity and the Kell blood groups: auto-anti-Kpb in a Kp(a+b-) patient. Manny N; Levene C; Sela R; Johnson CL; Mueller KA; Marsh WL Vox Sang; 1983; 45(3):252-6. PubMed ID: 6624011 [TBL] [Abstract][Full Text] [Related]
14. Delayed hemolytic transfusion reaction caused by the second example of anti-K19. Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F Transfusion; 1979; 19(5):604-8. PubMed ID: 505537 [TBL] [Abstract][Full Text] [Related]
15. BRIC 18: a monoclonal antibody with a specificity related to the kell blood group system. Parsons SF; Judson PA; Anstee DJ J Immunogenet; 1982 Dec; 9(6):377-80. PubMed ID: 7161507 [TBL] [Abstract][Full Text] [Related]
16. Unusual suppression of Kell system antigens in a healthy blood donor. Norman PC; Daniels GL Transfusion; 1988; 28(5):460-2. PubMed ID: 3420674 [TBL] [Abstract][Full Text] [Related]
17. Haematological changes associated with the McLeod phenotype of the Kell blood group system. Wimer BM; Marsh WL; Taswell HF; Galey WR Br J Haematol; 1977 Jun; 36(2):219-24. PubMed ID: 871435 [TBL] [Abstract][Full Text] [Related]
18. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. Carbonnet F; Hattab C; Collec E; Le van Kim C; Cartron JP; Bertrand O Br J Haematol; 1997 Mar; 96(4):857-63. PubMed ID: 9074432 [TBL] [Abstract][Full Text] [Related]